Skip to main content
Yantai Zhenghai Bio-Tech Co., Ltd. logo

Yantai Zhenghai Bio-Tech Co., Ltd. — Investor Relations & Filings

Ticker · 300653 ISIN · CNE100002NZ1 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 970 across all filing types
Latest filing 2020-04-09 Annual Report
Country CN China
Listing Shenzhen Stock Exchange 300653

About Yantai Zhenghai Bio-Tech Co., Ltd.

https://www.zhbio.com

Yantai Zhenghai Bio-Tech Co., Ltd. specializes in the research, development, production, and sale of regenerative medicine materials. The company focuses on tissue engineering and biomaterials to provide solutions for clinical repair and functional reconstruction. Its core product portfolio includes the Heal-All oral repair membrane, absorbable hard cerebral (spinal) membrane patches, and skin repair membranes. These products are widely utilized in stomatology, neurosurgery, and orthopedics. The company leverages advanced processing technologies to ensure biocompatibility and safety in its medical devices. By integrating research with clinical needs, it develops innovative bone repair materials and other biological scaffolds designed to facilitate natural tissue regeneration.

Recent filings

Filing Released Lang Actions
2019年年度报告
Annual Report Classification · 100% confidence The document is titled as the "2019 年年度报告全文" which translates to "2019 Annual Report Full Text" for 烟台正海生物科技股份有限公司. It contains detailed financial data, company business overview, risk factors, management discussion, and analysis sections typical of a full annual report. The document includes comprehensive financial figures for the year 2019, business descriptions, market analysis, and corporate governance information. It is not a brief announcement or a presentation but a full detailed report covering the entire fiscal year. Therefore, it fits the definition of an Annual Report (10-K). The document length is 15,000 characters, indicating it is a full report rather than a short announcement or summary. FY 2019
2020-04-09 Chinese
2019年度监事会工作报告
Board/Management Information Classification · 90% confidence The document is titled '监事会工作报告' which translates to 'Supervisory Board Work Report' for the year 2019. It details the supervisory board's activities, meetings, oversight of financial and operational matters, internal control evaluations, and plans for 2020. It references specific meetings and agenda items related to annual and quarterly reports but does not itself contain full financial statements or detailed financial data. The document is a report on the supervisory board's work rather than a full annual or interim financial report. It is not an announcement of a report publication but a substantive report on governance and supervisory activities. This fits best under the category of Board/Management Information (MANG), as it relates to the supervisory board's oversight and governance activities rather than a full financial report or audit report.
2020-04-09 Chinese
2019年度董事会工作报告
Board/Management Information Classification · 95% confidence The document is titled '董事会工作报告' which translates to 'Board of Directors Work Report' for the year 2019. It details the activities, meetings, resolutions, and performance of the company's board of directors throughout the year. It includes information on board meetings, committee operations, independent directors' duties, shareholder meetings, and future outlook. The content focuses on governance and management activities rather than financial statements or audit results. There is no indication that this is an announcement or a brief summary; it is a detailed report on board activities. Therefore, the document fits best under the category of Board/Management Information (MANG), which covers announcements of changes or reports related to the company's board or senior management work.
2020-04-09 Chinese
2019年度财务决算报告
Annual Report Classification · 95% confidence The document is titled as the '2019年度财务决算报告' which translates to '2019 Annual Financial Settlement Report'. It contains detailed financial statements including balance sheets, profit summaries, and explanations of major changes for the fiscal year 2019. The report is audited by a certified accounting firm, indicating it is a formal financial report. The length of the document is 3415 characters, which is relatively short but contains substantive financial data and analysis, not just an announcement or certification. The content matches the characteristics of an Annual Report (10-K) as it covers the full fiscal year financial performance and results. Therefore, the document should be classified as an Annual Report (10-K). FY 2019
2020-04-09 Chinese
融资与对外担保管理制度（2020年4月）
Governance Information Classification · 95% confidence The document is titled '融资与对外担保管理制度' which translates to 'Financing and External Guarantee Management System' of Yantai Zhenghai Biotechnology Co., Ltd. It is a detailed internal policy document outlining the procedures, approval authorities, risk management, and legal responsibilities related to the company's financing and external guarantees. The content includes governance rules, approval thresholds, risk controls, and legal compliance measures. There is no indication that this is a financial report, earnings release, or regulatory filing. It is not an announcement or a report publication notice but a governance and management system document. Therefore, it fits best under Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2020-04-09 Chinese
广发证券股份有限公司关于公司2019年度募集资金存放与使用情况的专项核查意见
Audit Report / Information Classification · 95% confidence The document is a detailed report from 广发证券股份有限公司 (Guangfa Securities Co., Ltd.) regarding the 2019 annual special audit opinion on the storage and use of raised funds by 烟台正海生物科技股份有限公司 (Yantai Zhenghai Biotechnology Co., Ltd.). It includes specific financial figures about the amount of funds raised, their allocation, usage, and balance as of December 31, 2019. The document references regulatory requirements and compliance with securities laws and stock exchange rules. It is a specialized audit and verification report focusing on the use of funds raised through an IPO and their management, rather than a full annual report or earnings release. The document length is 4555 characters, which is sufficient to contain substantive financial data and analysis related to the use of raised funds. This type of document fits the category of an Audit Report / Information (AR), as it is a standalone audit opinion on a specific financial aspect (funds raised and their use) and not a full annual report or other category. FY 2019
2020-04-09 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.